. 2002. 549. . .8(31)

57

543.544:615.07

.

" "

© 2002 . . * , . . *

, « - ».

. - .

« » (System suitability) ( ) ( ) (USP)

XXI . « » , - [1].

, - ,

( ).

[2] ,

, " ". , - , -

(

),

, .

" "

- , -

- - [3]. , ,

, ,

- . ,

, " ".

, , " "

, - , (

). , - , " -

". , -

.

" -

"

1. .

, .

* - , .

. . , . .

58

. (0.2-2 ).

, - .

. - (20-100 ). , ,

- , ( .1).

. .

5324, 1 .95

. .

1795, 3 .67

.1. , - : ( );

( ).

(

. .) .

: ( 1:100) -, (

). 2. . , -

, .

, - .

3. ( ). [4].

USP , 2% ;

2% [5] .

, , , - ,

5% 10% .

4. . , -

,

:

?

- ( ) ( -

).

,

?

,

. , - , .

, " - , -

59

?" : :

, .

: , ( )

( 0.1-1.0 10 -).

" ".

1. ( .2). [6] - -

-

- ( -) - ( -

) - -

. - -

0.1-0.5% - , 1%

. - -

- ,

, , - -

, - ( .3, -

). - ,

" - -, -

, 1.2. - ".

, - ( -

) , , - .

( .3, -

) ( ) - ( 1.4-1.6) -

-. ,

- [6],

.

, 1.4-1.5 -

O H

C H2

NH3C C H3

O C H3

HCl

HN

Cl

C O O N aCl

N

O

Cl Cl

C O O H

OO

C H3

C O O H

O H

1-(2,6- ) -2-

.2.

, .

. . , . .

60

( -

20 )

. , -

- , -

. , ( -

, D- L- ), - -

, - . -

- .

2. ( .2).

« -

» (1-(2,6-) -2- ) [7]: «

- 25

12 . « » -, 6.5».

-

(1 ). -

( .4), " ".

- , , , .

, - , 70% -

. - .

( ) , - (Nucleosil C8, Hepersil C8, Zorbax C8, NovaPak C8)

. , . ,

, 25 , 12 (

6 ), , , , .

, , , .

, .

3. ( .2).

1 , -

. , .

« » [8].

« . 0.10

10.0 .

(b). 10.0

10.0 . 1.0

0.2

100.0 -.

61

10 -

. « - »

, -

(b) 6.0.

250* 4.6 , - (5

) ( [9] Nucleosil C18).

(2:400:600).» , -

- .

( .5) (b) -

(0.1 0.2

10 , -) 4.5.

(100 - 10 ),

( .6),

. -

, - 10

100 , - 0.1 , -

- 8

- 20% ( .7).

, 7

- .

- «

-»

: -

. -

« -

». - -

, [10], .

.3 . - , « -

».

.4 . - , « -

» [7 ].

.5. - -

b, « -» -

[8 ,9 ].

. . , . .

62

1. -

(S/N)

- - -

, - ,

, -

, - -

, - - -

( .8).

- ,

, -

. 2. -

/ ( )

[11,12]. - -

. .9

,

. :

/P f g , g

, ,

, ;

f

.

.8. - (S/ N) [10-12].

.9 . / ( ) [11 ,12 ].

.6. - ,

« » - [8 ,9 ].

.7. - -

b , « »

[8 ,9 ]

22%.

63

/ ( ) (

) (

). , , , ,

. ,

. - -

RS -, -

( .10 ), -

.

3. .

-

" - ",

. -

-.

- -

" -

" -

.

-

n- (

), - ( ),

, - .

" "

" ", , -. , - , ,

, . 500

( ), ,

.

, " -

" [13-15], :

,

.10. ,

- / ( ) [12 ].

-

/

( ) ( ).

, -

/ ( ) -.

. . , . .

64

( ) 1000 .

, - (

), : 0.9 1.2 ( ); 0.8 1.6 ( , ); 2.0

- -

.

, - -

( , ), : 1-2% ; 5-10% -

100 ppm (0.01%).

,

( - ), 1.0 (

5.0% ); 1.5 ( 0.1% ); - 4.0.

« »

:

- , -

( ) 3.0.

/ ( ) , -

- ( ), 0.7 (

1.0).

, -

( - ) : 1 0.12; 2

0.25; , - 1.

-

50% ( -) .

, , - - ( -

).

1. Cox R., Menon G. Pharmeuropa. 1998. V.1. No.1. P.136 2. . ., . ., . . . 2001.

1. C.47-56. 3. . ., . ., . . . . 1996. 1/ 2. .16-29. 4. . . , . . , . . , . . , . . , . . -

. . 1996. 3. .12-22. 5. USP 24/ NF 19. The United States Pharmacopeia and National Formulary. Official from

1.01.2000. The United States Pharmacopeia Convention, Inc. 1999. 2563 p. 6. Deutsches Arzneibuch 10. Ausgabe (DAB 10). Deutscher Apotheker Verlag Stuttgart

Govi-Verlag GmbH Frankfurt. 1992. Band 1-4. 7. Diclofenac sodium. European Pharmacopeia 1997. Third edition. Council of Europe.

Strassbourg. P.1487-1488. 8. Acetylsalicylic asid. European Pharmacopeia Supplement 2000. Third edition. Council of

Europe. Strassbourg. P.334-336 9. Acetylsalicylic asid PA/ PH/ Exp. 10A/ T (97) 104. In European Pharmacopoeia

Comission. PA/PH/Exp. 3/T (98) 119, COM

65

10. Cyanocobalamin. European Pharmacopeia 1997. Third edition. Council of Europe.

Strassbourg. P.691-692 11. . . 1989. .: ,

399 . 12. Lough W.J., Wainer J.W. HPLC. Fundamental principles and practice. 1996. London-

Glasgow-Weinheim-New York-Tokyo-Melburn-Madras. 270 p. 13. -1-96

. 1. . 1996.

4/ 5 .7-19.

14. -1-96 . 2. . 1996.

6 .10-22. 15. -1-96

. 3. . 1996. 7 .12-21.

6 2002 .

Kharkov University Bulletin. 2002. 549. Chemical Series. Issue 8(31). A.Yu.Kulikov, A.G.Verushkin. High-performance liquid chromatography in pharmaceutical analysis. Sys-tem suitability test.

In this article some problems, appearing in developing of the chromatographical system suitability test are considered. Recommendations concerning selection of solution components for system suitabil-ity test are given and the recommended requirements for the given test are presented. The additional parameters for the system suitability test are considered.